Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 14;113(8):2888–2903. doi: 10.1111/cas.15402

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Inhibition of miR‐33a/b or activation of PD‐L1 reversed the effects of circPCBP2 knockdown on DLBCL properties. (A) Representative images of spheroids formed by DLBCL cells transfected with indicated plasmids. (B) Quantification of number of spheroids formed by transfected DLBCL cells. (C–F) Relative levels of OCT4 mRNA, Nanog mRNA, SOX2 mRNA, and ALDH1A1 mRNA in sh‐NC or sh‐circPCBP2 transfected DLBCL cells. (G, H) Flow cytometry analysis of the number of CD133‐positive cells following transfection. (I) Cell viability of transfected DLBCL cells upon CHOP treatment. (J, K) Percentage of apoptotic DLBCL cells following CHOP treatment